Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and rivaroxaban for bleeding and thrombosis management in lumbar posterior fixation fusion surgery
ChiCTR1900024985Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid and rivaroxaban in venous thromboembolism (VTE) and Not applicable (3 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Bleeding volume during operation, Bleeding volume after operation and 15 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
tranexamic acidrivaroxaban
03
Conditions
venous thromboembolism (VTE)Not applicable
Beyond the preview
Go deeper on ChiCTR1900024985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024985.